Wed, Oct 22, 2014, 11:29 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Boston Scientific Corporation Message Board

  • monkeymanlives monkeymanlives Nov 9, 2011 3:09 PM Flag

    ABT split and....

    acquisition of BSX... Drug-eluting stents are all the rage. Good chemistry w XIENCE. Seem likely?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Tidetrol

      Thanks again for the insight. Is this strut issue significant enough to keep FDA from granting Full Market approval?

      I fully realize this is a hot topic and you have already giving me some interesting info. Enough info that I am looking in a different direction now.

      Thanks again

    • The currently exposed issue with the bioabsorbable is strut fracture; which is bad enough.

      This bandaid has a long way to go before it's viable technology. The bars are set a lot higher today for use and acceptance then they were when the first stents were introduced.

    • Tidetrol

      I appreciate your insight. I am sure that all big three are working on bioabsorbable or at least taking a very serious look at it. Do you see all three coming up against the same obstacle? The breaking off of a piece of not yet dissolved stent six months to a year post implant or so and it going downstream issue.

      Thanks I'm learning I like it.

    • No harm no foul. Most everything rolls off like water from the back of a loon.

      I ran into someone a couple weeks ago that is working on a peripheral vascular project that I believe, very strongly, can help one of the current stent players working with bioabsorbables deliver a safe solution to managing the pieces of the dissolving stent until they are small enough not to cause a problem downstream.

      Like everything else, there are a couple major hurdles...but any of the big three in the industry already have 80% of the tools needed to clear the hurdles....and I know BSC has an 'old Scimed tool' they could dust the rust off of to help deliver the solution; the question is...who to talk to! The intellectual property associated with that old device has got to be expired by now; which would probably pave the way for others to build on what it was.

    • Tidetrol

      I had thought you had been around this for a while. I had no intention of speaking down to you in any way shape or form. If it was taken that way please accept my apologies. I am from other side of this cardiac industry (pacers, defib CRT-d)

      I will keep that in mind in the future.

      I would be interested to hear your views in more detail on what you see as the future of bioabsorbable. If it is dramatically different then mine?

    • ABT has the superior bioabsorbable stent, why would they want BSX junk stents? BSX is losing revenues, why would anybody buy a sinking ship?

12.32+0.29(+2.41%)Oct 22 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
NXP Semiconductors NV
NasdaqGSWed, Oct 22, 2014 4:00 PM EDT
Herbalife Ltd.
NYSEWed, Oct 22, 2014 4:00 PM EDT